Topic Hub
12 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 12 of 12 clinical reviews.
A complete clinical guide for adolescents ages 12-17 on ezetimibe (Zetia) transitioning to adult cardiology or primary care, covering dosing, monitoring, statin combination therapy, and what to tell your new provider.
Read clinical reviewA comprehensive clinical guide covering how ezetimibe (Zetia) affects daily school life, sports, PE class, and extracurricular activities for adolescents ages 12 to 17, with dosing context, side-effect timing, and practical management strategies.
Read clinical reviewA physician-reviewed guide to ezetimibe (Zetia) use in adults aged 65 and older, covering physical activity, cognitive engagement, daily routines, muscle side-effect monitoring, and practical safety tips.
Read clinical reviewA complete caregiver guide to giving ezetimibe (Zetia) to children under 12, covering FDA approval status, dosing, administration technique, side-effect monitoring, and when to call the prescriber.
Read clinical reviewA clinician-reviewed guide to ezetimibe use in children under 12, covering school accommodations, physical activity safety, PE participation, and what parents and teachers need to know.
Read clinical reviewComplete caregiver guidance on giving Zetia (ezetimibe) to adults aged 65 and older, including dosing, timing, drug interactions, monitoring, and practical administration tips backed by clinical evidence.
Read clinical reviewA clinician-reviewed guide to off-label ezetimibe use in adolescents ages 12 to 17, covering evidence from pediatric trials, dosing, safety, and guideline recommendations for familial hypercholesterolemia and related conditions.
Read clinical reviewA clinician-reviewed guide to ezetimibe use in geriatric patients, covering off-label applications, trial evidence, drug interactions, and practical dosing considerations for adults 65 and older.
Read clinical reviewA clinically detailed guide to ezetimibe (Zetia) use in geriatric patients aged 65 and older, covering pharmacokinetics, cardiovascular outcomes, dosing, drug interactions, and safety data from major trials including SHARP and IMPROVE-IT.
Read clinical reviewA clinician-reviewed guide to ezetimibe use in children under age 12, covering developmental safety data, FDA approval status, growth effects, neurodevelopmental considerations, and when pediatric cardiologists consider off-label use.
Read clinical reviewA clinician-reviewed guide to transitioning pediatric patients under age 12 on ezetimibe (Zetia) to adult lipid management. Covers FDA labeling, dosing, monitoring, and care coordination protocols.
Read clinical reviewA clinician-reviewed guide to off-label ezetimibe use in children younger than 12, covering evidence, dosing, safety, and current guideline positions for pediatric hypercholesterolemia.
Read clinical review